SPONSOR
Mirum Pharmaceuticals, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Chronic Hepatitis D InfectionAlagille SyndromeProgressive Familial Intrahepatic Cholestasis
Mirum Pharmaceuticals, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Chronic Hepatitis D Infection, Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Mirum Pharmaceuticals, Inc.
How many clinical trials has Mirum Pharmaceuticals, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Mirum Pharmaceuticals, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Chronic Hepatitis D Infection, Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Mirum Pharmaceuticals, Inc. research focus on?
Mirum Pharmaceuticals, Inc. clinical trials span Chronic Hepatitis D Infection, Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Mirum Pharmaceuticals, Inc. clinical trial?
To participate in a Mirum Pharmaceuticals, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Mirum Pharmaceuticals, Inc. trials with current recruitment status updated daily.
Clinical Trials by Mirum Pharmaceuticals, Inc.
NCT07200908 Phase 3
Recruiting
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Chronic Hepatitis D Infection
NCT06193928
Recruiting
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
Alagille Syndrome
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology